−1.18USD
−35.33 MUSD
991.47 KUSD
29.58 M
About CO DIAGNOSTICS INC COM USD0.001
Sector
Industry
CEO
Dwight Howard Egan
Website
Headquarters
Salt Lake City
Employees (FY)
155
Founded
2013
FIGI
BBG00XCCRL47
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0A50 is 1.13 USD — it has decreased by 1.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CO DIAGNOSTICS INC COM USD0.001 stocks are traded under the ticker 0A50.
CO DIAGNOSTICS INC COM USD0.001 is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
0A50 stock is 1.77% volatile and has beta coefficient of 1.55. Check out the list of the most volatile stocks — is CO DIAGNOSTICS INC COM USD0.001 there?
0A50 earnings for the last quarter are −0.20 USD per share, whereas the estimation was −0.29 USD resulting in a 31.03% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about CO DIAGNOSTICS INC COM USD0.001 earnings.
CO DIAGNOSTICS INC COM USD0.001 revenue for the last quarter amounts to 2.46 M USD despite the estimated figure of 200.00 K USD. In the next quarter revenue is expected to reach 3.63 M USD.
Yes, you can track CO DIAGNOSTICS INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
0A50 stock has fallen by 2.59% compared to the previous week, the last month showed zero change in price, over the last year CO DIAGNOSTICS INC COM USD0.001 has showed a 24.67% decrease.
0A50 net income for the last quarter is −14.68 M USD, while the quarter before that showed −5.98 M USD of net income which accounts for −145.34% change. Track more CO DIAGNOSTICS INC COM USD0.001 financial stats to get the full picture.
Today CO DIAGNOSTICS INC COM USD0.001 has the market capitalization of 35.64 M, it has decreased by 1.71% over the last week.
No, 0A50 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0A50 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CO DIAGNOSTICS INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 155.00 employees. See our rating of the largest employees — is CO DIAGNOSTICS INC COM USD0.001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CO DIAGNOSTICS INC COM USD0.001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CO DIAGNOSTICS INC COM USD0.001 stock shows the sell signal. See more of CO DIAGNOSTICS INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CO DIAGNOSTICS INC COM USD0.001 future price: according to them, 0A50 price has a max estimate of 2.50 USD and a min estimate of 2.50 USD. Read a more detailed CO DIAGNOSTICS INC COM USD0.001 forecast: see what analysts think of CO DIAGNOSTICS INC COM USD0.001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CO DIAGNOSTICS INC COM USD0.001 EBITDA is −41.45 M USD, and current EBITDA margin is −4.77 K%. See more stats in CO DIAGNOSTICS INC COM USD0.001 financial statements.